# Dave Inc.: overview

DAVE · Nasdaq · CIK 1841408 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/dave.md) · [Financials](/companies/dave/financials.md) · [Filings](/companies/dave/filings.md) · [Insiders](/companies/dave/insiders.md)

Latest reported revenue: [$170.8m](/filings/0001193125-26-335154.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 5, 2026 (XBRL us-gaap:Revenues, accession 0001193125-26-335154).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [92.5](/filings/0001193125-25-264819.md) | [101 d](/filings/0001193125-26-085370.md) | [108](/filings/0001193125-26-206446.md) | [132](/filings/0001193125-26-335154.md) | [151](/filings/0001193125-25-264819.md) | [164 d](/filings/0001193125-26-085370.md) | [158](/filings/0001193125-26-206446.md) | [171](/filings/0001193125-26-335154.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [0.5%](/filings/0001193125-25-264819.md) | [16.7% d](/filings/0001193125-26-085370.md) | [26.7%](/filings/0001193125-26-206446.md) | [6.9%](/filings/0001193125-26-335154.md) | [61.1%](/filings/0001193125-25-264819.md) | [40.3% d](/filings/0001193125-26-085370.md) | [36.6%](/filings/0001193125-26-206446.md) | [3.9%](/filings/0001193125-26-335154.md) |
| Diluted EPS | $ per share | [0.03](/filings/0001193125-25-264819.md) | not reported | [1.97](/filings/0001193125-26-206446.md) | [0.62](/filings/0001193125-26-335154.md) | [6.34](/filings/0001193125-25-264819.md) | not reported | [4.02](/filings/0001193125-26-206446.md) | [0.49](/filings/0001193125-26-335154.md) |
| Free cash flow | $m | [37.0 d](/filings/0001193125-25-264819.md) | [41.7 d](/filings/0001193125-26-085370.md) | [45.2](/filings/0001193125-26-206446.md) | [68.1 d](/filings/0001193125-26-335154.md) | [83.2 d](/filings/0001193125-25-264819.md) | [93.2 d](/filings/0001193125-26-085370.md) | [82.0](/filings/0001193125-26-206446.md) | [68.1 d](/filings/0001193125-26-335154.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [153](/filings/0000950170-23-007591.md) | [205](/filings/0000950170-24-026024.md) | [259](/filings/0001193125-26-085370.md) | [347](/filings/0001193125-26-085370.md) | [554](/filings/0001193125-26-085370.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [(4.2%)](/filings/0001193125-22-085334.md) | not reported | not reported | not reported | not reported |
| Net margin | % | [(13.1%)](/filings/0000950170-23-007591.md) | [(62.9%)](/filings/0000950170-24-026024.md) | [(18.7%)](/filings/0001193125-26-085370.md) | [16.7%](/filings/0001193125-26-085370.md) | [35.3%](/filings/0001193125-26-085370.md) |
| Diluted EPS | $ per share | [(4.69)](/filings/0000950170-23-007591.md) | [(11.12)](/filings/0000950170-24-026024.md) | [(4.07)](/filings/0001193125-26-085370.md) | [4.19](/filings/0001193125-26-085370.md) | [13.53](/filings/0001193125-26-085370.md) |
| Free cash flow | $m | [(0.9)](/filings/0000950170-23-007591.md) | [(45.6)](/filings/0000950170-24-026024.md) | [33.1](/filings/0001193125-26-085370.md) | [125](/filings/0001193125-26-085370.md) | [290](/filings/0001193125-26-085370.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/dave/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $621.5m | 1,667,948 |  | Added +839,351 |
| [Hood River Capital Management LLC](/funds/1578177.md) | 2026-06-30 | $411.4m | 1,104,277 |  | Reduced −41,624 |
| [Divisadero Street Capital Management, LP](/funds/1901865.md) | 2026-06-30 | $260.6m | 699,366 |  | Added +58,526 |
| [FMR LLC](/funds/315066.md) | 2026-06-30 | $178.7m | 479,746 |  | Added +248,711 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $176.7m | 474,139 |  | Reduced −29,389 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $151.6m | 406,752 |  | Added +172,964 |
| [RENAISSANCE TECHNOLOGIES LLC](/funds/1037389.md) | 2026-06-30 | $136.9m | 367,378 |  | Reduced −64,422 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $127.4m | 341,843 |  | Added +15,503 |
| [Driehaus Capital Management LLC](/funds/938206.md) | 2026-06-30 | $123.5m | 331,537 |  | Added +269,203 |
| [JANE STREET GROUP, LLC](/funds/1595888.md) | 2026-06-30 | $121.4m | 325,800 | Call | Added +184,800 |

## Recent filings

[All 417 filings](/companies/dave/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-15 | 17:00 ET | [SCHEDULE 13D/A](/filings/0001193125-26-392095.md) | Ownership report, active investor, amended | 0001193125-26-392095 |
| 2026-08-14 | 16:30 ET | [8-K](/filings/0001193125-26-352390.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-352390 |
| 2026-08-05 | 16:16 ET | [10-Q](/filings/0001193125-26-335154.md) | Quarterly report, period 2026-06-30 | 0001193125-26-335154 |
| 2026-08-05 | 16:11 ET | [8-K](/filings/0001193125-26-335119.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-335119 |
| 2026-06-02 | 17:00 ET | [8-K](/filings/0001193125-26-253774.md) | 5.07 Shareholder vote results | 0001193125-26-253774 |
| 2026-05-05 | 16:16 ET | [8-K](/filings/0001193125-26-206471.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-206471 |
| 2026-05-05 | 16:15 ET | [10-Q](/filings/0001193125-26-206446.md) | Quarterly report, period 2026-03-31 | 0001193125-26-206446 |
| 2026-04-20 | 17:00 ET | [DEF 14A](/filings/0001193125-26-164199.md) | Proxy statement, period 2026-04-20 | 0001193125-26-164199 |
| 2026-03-09 | 17:10 ET | [8-K](/filings/0001193125-26-098802.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-098802 |
| 2026-03-06 | 19:24 ET | [8-K](/filings/0001193125-26-094530.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-094530 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001193125-26-085370.md), filed Mar 2, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/b07778e6-b27c-4c3c-8d16-6628f5ed1d40)

## About the filer

- CIK: 1841408
- Tickers: DAVE, DAVEW
- Exchange: Nasdaq
- SIC code: 6199 Finance Services
- State of incorporation: not reported
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.